1. Home
  2. LGND vs CCS Comparison

LGND vs CCS Comparison

Compare LGND & CCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • CCS
  • Stock Information
  • Founded
  • LGND 1987
  • CCS 2000
  • Country
  • LGND United States
  • CCS United States
  • Employees
  • LGND N/A
  • CCS N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • CCS Homebuilding
  • Sector
  • LGND Health Care
  • CCS Consumer Discretionary
  • Exchange
  • LGND Nasdaq
  • CCS Nasdaq
  • Market Cap
  • LGND 2.0B
  • CCS 1.7B
  • IPO Year
  • LGND 1992
  • CCS 2014
  • Fundamental
  • Price
  • LGND $124.30
  • CCS $58.18
  • Analyst Decision
  • LGND Strong Buy
  • CCS Buy
  • Analyst Count
  • LGND 8
  • CCS 5
  • Target Price
  • LGND $144.71
  • CCS $80.75
  • AVG Volume (30 Days)
  • LGND 139.7K
  • CCS 421.0K
  • Earning Date
  • LGND 08-05-2025
  • CCS 07-23-2025
  • Dividend Yield
  • LGND N/A
  • CCS 2.00%
  • EPS Growth
  • LGND N/A
  • CCS 7.67
  • EPS
  • LGND N/A
  • CCS 9.70
  • Revenue
  • LGND $181,488,000.00
  • CCS $4,352,977,000.00
  • Revenue This Year
  • LGND $18.41
  • CCS N/A
  • Revenue Next Year
  • LGND $18.87
  • CCS $7.90
  • P/E Ratio
  • LGND N/A
  • CCS $5.98
  • Revenue Growth
  • LGND 53.40
  • CCS 11.97
  • 52 Week Low
  • LGND $81.74
  • CCS $50.42
  • 52 Week High
  • LGND $129.90
  • CCS $108.42
  • Technical
  • Relative Strength Index (RSI)
  • LGND 64.68
  • CCS 62.08
  • Support Level
  • LGND $120.68
  • CCS $60.00
  • Resistance Level
  • LGND $127.07
  • CCS $63.74
  • Average True Range (ATR)
  • LGND 3.76
  • CCS 2.12
  • MACD
  • LGND 0.86
  • CCS 0.44
  • Stochastic Oscillator
  • LGND 81.95
  • CCS 72.87

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing, and selling of single-family attached and detached homes. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its sales representatives and independent real estate brokers. The company generates the majority of its revenue from the Mountain segment.

Share on Social Networks: